Literature DB >> 6144937

New combination chemotherapy for relapsed acute myeloid leukaemia.

A M Worsley, D Catovsky, J M Goldman, D A Galton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6144937     DOI： 10.1016/s0140-6736(84)91709-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Chemotherapy for relapsed and resistant acute nonlymphoblastic leukemia. Effect of ATA, an amsacrine-containing regime.

Authors:  R Liang; T K Chan; D Todd
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Etoposide and teniposide in the treatment of acute leukemia.

Authors:  M Björkholm
Journal:  Med Oncol Tumor Pharmacother       Date:  1990
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.